wb777 com

wb777 com Natixis Advisors LLC lifted its holdings in shares of Burlington Stores, Inc. ( NYSE:BURL – Free Report ) by 66.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,419 shares of the company’s stock after acquiring an additional 8,939 shares during the quarter. Natixis Advisors LLC’s holdings in Burlington Stores were worth $5,907,000 at the end of the most recent quarter. Other hedge funds have also bought and sold shares of the company. Archer Investment Corp raised its stake in shares of Burlington Stores by 35.7% during the 3rd quarter. Archer Investment Corp now owns 570 shares of the company’s stock worth $150,000 after purchasing an additional 150 shares during the period. CIBC Asset Management Inc raised its position in Burlington Stores by 5.4% in the third quarter. CIBC Asset Management Inc now owns 2,283 shares of the company’s stock worth $602,000 after acquiring an additional 116 shares during the period. OneDigital Investment Advisors LLC boosted its stake in Burlington Stores by 5.5% in the third quarter. OneDigital Investment Advisors LLC now owns 1,027 shares of the company’s stock valued at $271,000 after acquiring an additional 54 shares during the last quarter. Metis Global Partners LLC bought a new position in shares of Burlington Stores during the 3rd quarter valued at approximately $216,000. Finally, Zions Bancorporation N.A. lifted its stake in Burlington Stores by 19.7% in the third quarter. Zions Bancorporation N.A. now owns 10,573 shares of the company’s stock valued at $2,786,000 after purchasing an additional 1,738 shares during the last quarter. Insiders Place Their Bets In other news, Director Paul Sullivan sold 1,705 shares of the business’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $277.05, for a total value of $472,370.25. Following the sale, the director now directly owns 7,393 shares of the company’s stock, valued at $2,048,230.65. The trade was a 18.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website . 0.91% of the stock is currently owned by company insiders. Burlington Stores Trading Up 4.9 % Burlington Stores ( NYSE:BURL – Get Free Report ) last announced its quarterly earnings results on Thursday, August 29th. The company reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.25. Burlington Stores had a return on equity of 47.43% and a net margin of 4.18%. The company had revenue of $2.47 billion for the quarter, compared to the consensus estimate of $2.42 billion. During the same quarter in the previous year, the business earned $0.60 EPS. Burlington Stores’s revenue was up 13.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Burlington Stores, Inc. will post 7.94 EPS for the current year. Wall Street Analyst Weigh In BURL has been the subject of a number of recent research reports. Loop Capital raised their target price on Burlington Stores from $270.00 to $345.00 and gave the stock a “buy” rating in a research report on Friday, August 30th. UBS Group increased their target price on shares of Burlington Stores from $270.00 to $280.00 and gave the stock a “neutral” rating in a research report on Thursday, November 14th. TD Cowen boosted their price target on shares of Burlington Stores from $279.00 to $288.00 and gave the company a “buy” rating in a research report on Friday, August 30th. Evercore ISI raised their price objective on shares of Burlington Stores from $300.00 to $315.00 and gave the stock an “outperform” rating in a report on Friday, August 30th. Finally, Wells Fargo & Company boosted their target price on shares of Burlington Stores from $300.00 to $325.00 and gave the company an “overweight” rating in a report on Friday, August 23rd. Two investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $297.56. View Our Latest Research Report on BURL Burlington Stores Company Profile ( Free Report ) Burlington Stores, Inc operates as a retailer of branded merchandise in the United States. The company provides fashion-focused merchandise, including women's ready-to-wear apparel, menswear, youth apparel, footwear, accessories, toys, gifts, and coats, as well as baby, home, and beauty products. Featured Articles Want to see what other hedge funds are holding BURL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Burlington Stores, Inc. ( NYSE:BURL – Free Report ). Receive News & Ratings for Burlington Stores Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burlington Stores and related companies with MarketBeat.com's FREE daily email newsletter .Avior Wealth Management LLC decreased its position in STERIS plc ( NYSE:STE – Free Report ) by 11.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,036 shares of the medical equipment provider’s stock after selling 133 shares during the quarter. Avior Wealth Management LLC’s holdings in STERIS were worth $251,000 as of its most recent filing with the Securities and Exchange Commission. A number of other institutional investors and hedge funds also recently added to or reduced their stakes in STE. Ashton Thomas Securities LLC purchased a new position in shares of STERIS during the third quarter valued at approximately $25,000. Central Pacific Bank Trust Division purchased a new position in shares of STERIS during the 3rd quarter worth $28,000. Quent Capital LLC lifted its stake in shares of STERIS by 112.7% during the 1st quarter. Quent Capital LLC now owns 134 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 71 shares during the period. Versant Capital Management Inc boosted its holdings in shares of STERIS by 2,262.5% during the second quarter. Versant Capital Management Inc now owns 189 shares of the medical equipment provider’s stock worth $41,000 after purchasing an additional 181 shares during the last quarter. Finally, Brown Brothers Harriman & Co. grew its position in shares of STERIS by 154.7% in the second quarter. Brown Brothers Harriman & Co. now owns 191 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 116 shares during the period. 94.69% of the stock is currently owned by hedge funds and other institutional investors. Analyst Upgrades and Downgrades A number of analysts have issued reports on the company. Stephens reissued an “overweight” rating and issued a $260.00 price target on shares of STERIS in a research note on Thursday, November 7th. JMP Securities reissued a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Monday, November 18th. KeyCorp upped their price target on shares of STERIS from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 3rd. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Friday, November 8th. Finally, Piper Sandler upgraded STERIS from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $230.00 to $260.00 in a report on Thursday, October 24th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $253.00. STERIS Price Performance STE opened at $214.34 on Friday. STERIS plc has a 52-week low of $195.47 and a 52-week high of $248.24. The company has a 50 day moving average of $227.89 and a two-hundred day moving average of $228.49. The company has a market cap of $21.16 billion, a P/E ratio of 48.94 and a beta of 0.85. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. STERIS ( NYSE:STE – Get Free Report ) last announced its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.12 by $0.02. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.33 billion. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.03 EPS. On average, analysts expect that STERIS plc will post 9.15 earnings per share for the current year. STERIS Announces Dividend The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Tuesday, November 19th will be issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.06%. The ex-dividend date is Tuesday, November 19th. STERIS’s dividend payout ratio is presently 52.05%. Insider Buying and Selling at STERIS In other STERIS news, CFO Michael J. Tokich sold 23,332 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total value of $5,763,004.00. Following the completion of the transaction, the chief financial officer now directly owns 42,930 shares of the company’s stock, valued at $10,603,710. This represents a 35.21 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website . 1.14% of the stock is owned by corporate insiders. STERIS Company Profile ( Free Report ) STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. See Also Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter .Young men swung to the right for Trump after a campaign dominated by masculine appeals

Kingsview Wealth Management LLC reduced its position in shares of APA Co. ( NASDAQ:APA – Free Report ) by 68.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,265 shares of the company’s stock after selling 22,567 shares during the period. Kingsview Wealth Management LLC’s holdings in APA were worth $251,000 as of its most recent filing with the Securities and Exchange Commission. Several other institutional investors and hedge funds also recently made changes to their positions in APA. Woodstock Corp lifted its holdings in APA by 20.3% during the 3rd quarter. Woodstock Corp now owns 308,253 shares of the company’s stock worth $7,540,000 after buying an additional 51,993 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of APA by 4.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 11,991,513 shares of the company’s stock worth $293,312,000 after acquiring an additional 485,291 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of APA by 13.5% in the third quarter. Victory Capital Management Inc. now owns 1,261,324 shares of the company’s stock worth $30,852,000 after acquiring an additional 149,762 shares during the period. Ellis Investment Partners LLC bought a new stake in APA in the second quarter valued at approximately $2,499,000. Finally, AQR Capital Management LLC increased its position in APA by 112.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,448,935 shares of the company’s stock valued at $42,092,000 after purchasing an additional 767,557 shares during the period. Institutional investors and hedge funds own 83.01% of the company’s stock. Analysts Set New Price Targets A number of research analysts have recently issued reports on APA shares. UBS Group dropped their price target on shares of APA from $29.00 to $28.00 and set a “neutral” rating on the stock in a research report on Monday, November 18th. Piper Sandler cut their price target on shares of APA from $28.00 to $26.00 and set a “neutral” rating on the stock in a research report on Monday, November 18th. Royal Bank of Canada lowered their price objective on APA from $34.00 to $32.00 and set a “sector perform” rating for the company in a research report on Monday, November 11th. JPMorgan Chase & Co. cut their target price on APA from $29.00 to $25.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 13th. Finally, Evercore ISI lowered their target price on APA from $39.00 to $33.00 and set an “in-line” rating for the company in a report on Monday, September 30th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $32.57. APA Trading Up 0.6 % APA opened at $22.65 on Friday. APA Co. has a fifty-two week low of $21.15 and a fifty-two week high of $37.82. The firm has a market capitalization of $8.38 billion, a PE ratio of 3.18 and a beta of 3.24. The company has a debt-to-equity ratio of 1.03, a current ratio of 1.24 and a quick ratio of 1.24. The company’s 50-day moving average is $24.15 and its 200 day moving average is $27.20. APA Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Friday, November 22nd. Stockholders of record on Tuesday, October 22nd were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 4.42%. The ex-dividend date of this dividend was Tuesday, October 22nd. APA’s dividend payout ratio (DPR) is presently 14.12%. About APA ( Free Report ) APA Corporation, an independent energy company, explores for, develops, and produces natural gas, crude oil, and natural gas liquids. It has oil and gas operations in the United States, Egypt, and North Sea. The company also has exploration and appraisal activities in Suriname, as well as holds interests in projects located in Uruguay and internationally. Further Reading Receive News & Ratings for APA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for APA and related companies with MarketBeat.com's FREE daily email newsletter .

Kingsview Wealth Management LLC Makes New Investment in Reddit, Inc. (NYSE:RDDT)Fellowship: Bible lessons, sensory-friendly services and more at Sewickley area churches

Los Angeles Chargers (7-4) at Atlanta (6-5) Sunday, 1 p.m. EST, CBS Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get any of our free email newsletters — news headlines, obituaries, sports, and more.